Search results
Could an FDA-approved cancer drug help stop Parkinson's disease progression?
MedicalNewsToday via AOL· 5 hours agoAn existing cancer drug has shown promise in halting Parkinson's disease progression in mouse...
A new COVID variant is dominant in the US: What are its symptoms?
TODAY via Yahoo News· 12 hours agoThe new "FLiRT" COVID-19 variants, including KP.3 and KP.2, are spreading in the United States. Will...
Alzheimer's drug's potentially fatal side effect, ARIA, obscured by 'soothing acronym,' doctors say
LA Times via Yahoo News· 5 days agoGenevieve Lane, who took Leqembi, died of a mysterious side effect called ARIA. Her death, and those...
Symptoms of the KP.3 COVID Variant, the New Dominant Strain
Prevention via Yahoo News· 4 days agoIf you’re in what’s considered an incredibly high-risk group, you may want to talk to your doctor...
Beyond BCMA-Directed CAR T-Cell Therapy
MedPage Today· 1 day agoAlthough survival rates for patients with multiple myeloma are improving, with a 5-year rate of about 60%, many patients relapse after treatment. "Patients have seen impressive advances in survival ...
EHA 2024: Monoclonal antibodies continue to dominate multiple myeloma treatments
Pharmaceutical Technology via Yahoo Finance· 14 hours agoAccording to GlobalData's Multiple Myeloma: Global Drug Forecast and Market Analysis to 2027,...
Beyond the lung: treating the GI symptoms of Covid-19
Pharmaceutical Technology via Yahoo Finance· 4 days agoCovid-19 is more than a respiratory disease, the presence of gastrointestinal (GI) symptoms are an...
US FDA puts partial clinical hold on BioNTech's early-stage study of cancer drug
Reuters via Yahoo News· 5 days agoThe drug, an antibody-drug conjugate (ADC), was being studied in a trial sponsored by China-based...
Cessation to launch Phase IIa monoclonal antibody trial in opioid abuse
Clinical Trials Arena via Yahoo Finance· 2 days agoCSX-1004 is an investigational, recombinant human immunoglobulin G (IgG)1λ monoclonal antibody which...
Regeneron touts success with bispecific antibody in multiple myeloma trial
Clinical Trials Arena via Yahoo Finance· 5 days ago“In contrast to the currently existing treatments, where [a patient] stays five or eight days in the...